Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Elutia Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 21 | 24 | +3 |
| Shares | 6.59M | 6.89M | +294.4K (+4.5%) |
| Value | $9.20M | $14.9M | +$5.68M (+61.7%) |
New holders (5)
Institutions that held Elutia Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 21,192 | $45.8K | 0.00% |
| Northern Trust Corp | 13,324 | $28.8K | 0.00% |
| XTX Topco Ltd | 11,380 | $24.6K | 0.01% |
| Virtu Financial LLC | 11,328 | $24.0K | 0.00% |
| Bank of America Corp | 5 | $11 | 0.00% |
Sold out (2)
Institutions that held Elutia Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 663,244 | $942.5K |
| Prosight Management, LP | 25,594 | $36.6K |